DENISE HOFFMAN: Open Payments
NPI 1821458217 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,456 in 63 payments from 13 companies in 2025. Trend: 2023 $1,821 · 2024 $1,412 · 2025 $1,456
Food & beverage: $1,356Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $382 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $299 |
| Janssen Biotech, Inc. | 11 | $266 |
| ABBVIE INC. | 6 | $115 |
| Astellas Pharma US Inc | 4 | $94 |
| DENTSPLY IH AB | 2 | $82 |
| PFIZER INC. | 4 | $62 |
| Medtronic, Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Boston Scientific Corporation | 1 | $27 |
Products named: GEMTESA, ERLEADA, Xofigo, Xtandi, Nubeqa, LOFRIC, BOTOX, LUPRON DEPOT.
Industry payments across PA — which companies pay providers there.
